Literature DB >> 26659385

Partial nephrectomy after selective embolization of tumor vessels in a hybrid operating room: A new approach of zero ischemia in renal surgery.

Pierre Bigot1, Antoine Bouvier2, Paul Panayotopoulos1, Christophe Aubé2, Abdel Rahmène Azzouzi1.   

Abstract

It is established that partial nephrectomy is the standard of care for tumors confined to the kidney. Achieving a partial nephrectomy without renal ischemia and limiting operative bleeding is the subject of numerous researches. Since 2010, hybrid operating rooms have been used to perform both interventional radiology and surgical procedures at the same place and time. We used this latest technology to treat 3 patients with localized kidney tumors. The tumors were of moderate complexity and all were treated after immediate hyperselective embolization by laparoscopic surgery without dissection and clamping of the renal pedicle. The embolization of tumor vessels could be performed using image-stitching software. After embolization, operative time was 50, 70 and 80 minutes and blood loss was less than 100 ml for each case. Postoperative control 3D arteriography confirmed the respect of the vascularization of the healthy renal parenchyma. No postoperative complications occurred. Combined approach including hyperselective embolization and partial nephrectomy in the same time in a dedicated operating room is a new approach of zero ischemia during partial nephrectomy which reduces the difficulty of the surgery, limits injury to the kidney and increases patient safety.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  hybrid operating room; nephron sparing surgery; renal cell carcinoma; selective embolization; surgical treatment

Mesh:

Year:  2015        PMID: 26659385     DOI: 10.1002/jso.24120

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  1 in total

1.  Intraoperative modulation of arterial blood flow in a hybrid operating room: A report of three cases.

Authors:  Yoshikatsu Saitoh; Yasuyuki Hara; Shigehito Miyagi; Chikashi Nakanishi; Wataru Nakanishi; Ryuichi Nishimura; Daijirou Akamatsu; Hitoshi Goto; Michiaki Unno; Takashi Kamei
Journal:  Clin Case Rep       Date:  2019-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.